News about Globe Life

Globe Life (GL) reported Q3 net operating EPS of $4.84, up 1%, and premium revenue up 7% to $1.3 billion. Its United American health underwriting margin fell to negative $6 million from $16 million a year ago, due to a $7 million CMS processing delay and a $16 million underwriting loss at the startup Evry unit. The company revised its 2026 net operating EPS guidance to $15.35–$15.65 but set 2027 guidance at $16.10–$17.10. It projects excess parent-company cash flow of $850–$950 million in 2027, mainly for share buybacks and dividends.

Globe Life (NYSE: GL) reported third-quarter net income of $4.62 per diluted share, down from $4.73 a year earlier, while net operating income rose to $4.84 from $4.81. Net income as an ROE was 19.7% for the first nine months, book value per share climbed 23% to $85.35, and total premium revenue grew 7%. Life operations at American Income Life and Liberty National saw premiums and net sales rise 4% to 7%, and the average producing agent count at Liberty National increased 9%. The Family Heritage health division grew its underwriting margin 12%. The company repurchased 1.1 million shares for $185 million during the quarter, and administrative expenses held at 7.3% of premium, unchanged from a year earlier.